Literature DB >> 20168234

Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.

Andres Jaussi1, Georg Noll, Bernhard Meier, Roger Darioli.   

Abstract

BACKGROUND: There may be a considerable gap between LDL cholesterol (LDL-C) and blood pressure (BP) goal values recommended by the guidelines and results achieved in daily practice.
DESIGN: Prospective cross-sectional survey of cardiovascular disease risk profiles and management with focus on lipid lowering and BP lowering in clinical practice.
METHODS: In phase 1, the cardiovascular risk of patients with known lipid profile visiting their general practitioner was anonymously assessed in accordance to the PROCAM-score. In phase 2, high-risk patients who did not achieve LDL-C goal less than 2.6 mmol/l in phase 1 could be further documented.
RESULTS: Six hundred thirty-five general practitioners collected the data of 23 892 patients with known lipid profile. Forty percent were high-risk patients (diabetes mellitus or coronary heart disease or PROCAM-score >20%), compared with 27% estimated by the physicians. Goal attainment rate was almost double for BP than for LDL-C in high-risk patients (62 vs. 37%). Both goals were attained by 25%. LDL-C values in phase 1 and 2 were available for 3097 high-risk patients not at LDL-C goal in phase 1; 32% of patients achieved LDL-C goal of less than 2.6 mmol/l after a mean of 17 weeks. The most successful strategies for LDL-C reduction were implemented in only 22% of the high-risk patients.
CONCLUSION: Although patients at high cardiovascular risk were treated more intensively than low or medium risk patients, the majority remained insufficiently controlled, which is an incentive for intensified medical education. Adequate implementation of Swiss and International guidelines would expectedly contribute to improved achievement of LDL-C and BP goal values in daily practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20168234     DOI: 10.1097/HJR.0b013e328333c1d9

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial.

Authors:  Charles B Eaton; Donna R Parker; Jeffrey Borkan; Jerome McMurray; Mary B Roberts; Bing Lu; Roberta Goldman; David K Ahern
Journal:  Ann Fam Med       Date:  2011 Nov-Dec       Impact factor: 5.166

2.  Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.

Authors:  James P Sheppard; Kate Fletcher; Richard J McManus; Jonathan Mant
Journal:  Br J Gen Pract       Date:  2014-01       Impact factor: 5.386

3.  Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.

Authors:  Li-Ting Ho; Wei-Hsian Yin; Shao-Yuan Chuang; Wei-Kung Tseng; Yen-Wen Wu; I-Chang Hsieh; Tsung-Hsien Lin; Yi-Heng Li; Lien-Chi Huang; Kuo-Yang Wang; Kwo-Chang Ueng; Ching-Chang Fang; Wen-Harn Pan; Hung-I Yeh; Chau-Chung Wu; Jaw-Wen Chen
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

4.  Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.

Authors:  Diane M A Swallow; Michael A Lawton; Katherine A Grosset; Naveed Malek; Johannes Klein; Fahd Baig; Claudio Ruffmann; Nin P Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; Huw R Morris; Nigel Williams; Nicholas W Wood; Michele T M Hu; Donald G Grosset
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-09-26       Impact factor: 10.154

5.  Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation.

Authors:  Diana N Vikulova; Ilia S Skorniakov; Brendon Bitoiu; Chad Brown; Emilie Theberge; Christopher B Fordyce; Gordon A Francis; Karin H Humphries; G B John Mancini; Simon N Pimstone; Liam R Brunham
Journal:  Am J Prev Cardiol       Date:  2020-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.